AMD Lost $7.75 Billion in Revenue at a Single Question
Hunterbrook’s short report doesn’t prove a violation. It prices the risk if licensing tightens.
Hunterbrook’s short report doesn’t prove a violation. It prices the risk if licensing tightens.
A record NGS ARR beat, lifted full-year targets, and a $4.5B AI deal hit Wednesday night. Here is why PANW…
Tariff refunds, advertising growth, and e-commerce strength rewrote Q2.
CGON surged 14% on a landmark bladder cancer result, then gave back gains. Here is what investors need to weigh…
CMS’s new CRUSH audit proposal targets Medicare Advantage payments, and UnitedHealth has not yet quantified the exposure.
Xi and Carney signed a trade deal in Shenzhen today, putting about C$400 million in Canadian exports on better terms…
Goldman and Morgan Stanley decide Wednesday evening if $78 still holds.
Phase 3 knee OA results pull obesity drugs into pain coverage.
With talc bills and Stelara pressure still on the books, is this the best use of JNJ's cash for dividend…
BABA reports Thu, Nov. 19 with EPS expected to jump year over year, but a 7% selloff shows export-control fear…